NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球移動醫療市場:按類型,關聯組織和應用分類的機會分析和行業預測:2020-2027

mHealth Market by Type, Stakeholders, and Application : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 944181
出版日期 內容資訊 英文 362 Pages
商品交期: 2-3個工作天內
價格
全球移動醫療市場:按類型,關聯組織和應用分類的機會分析和行業預測:2020-2027 mHealth Market by Type, Stakeholders, and Application : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年04月01日內容資訊: 英文 362 Pages
簡介

全球移動醫療市場預計將從2019年的460.48億美元增長到2027年的2304.19億美元,從2020年到2027年的複合年增長率為22.3%是。移動醫療是電子醫療的重要組成部分之一,電子醫療是利用計算機進行醫療保健的一項舉措。除了收集和儲存的努力外,還正在努力監測和治療患有急性和慢性疾病的患者。使用移動醫療設備和服務的臨床領域包括心血管疾病,糖尿病,呼吸道,神經病學等,血糖儀,血壓監測儀,脈搏血氧儀,神經學監測儀,心臟健康監測器和其他移動健康設備已投放市場。推動市場擴張的因素包括與生活方式有關的疾病的流行,技術創新,政府激勵措施以及無線技術與便攜式醫療設備的集成。

此報告調查了全球移動醫療市場,並提供了諸如市場概述,類型,附屬,用途,地理分析,競爭格局和關鍵公司概況之類的信息。

內容

第1章簡介

第2章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要公司的地位
  • 促進產業和市場形成的主力軍(移動醫療設備)
  • 市場動態
    • 促進增長的因素
    • 生長抑製劑
    • 市場機會
    • 影響分析

第4章市場分析:按類型

  • 概述
    • 市場規模和預測
  • 移動醫療設備
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和類型預測
    • 市場規模和地區預測
    • 國家市場分析
  • 移動健康服務
    • 主要市場趨勢,增長因素,機遇
    • 市場規模和類型預測
    • 市場規模和地區預測
    • 國家市場分析

第5章市場分析:按相關組織

  • 概述
    • 市場規模和預測
  • 移動運營商
    • 市場規模和地區預測
    • 國家市場分析
  • 設備供應商
    • 市場規模和地區預測
    • 國家市場分析
  • 醫療保健提供者
    • 市場規模和地區預測
    • 國家市場分析
  • 應用程序和內容公司
    • 市場規模和地區預測
    • 國家市場分析

第6章市場分析:按用法

  • 概述
    • 市場規模和預測
  • 心血管疾病
    • 市場規模和地區預測
    • 國家市場分析
  • 糖尿病
    • 市場規模和地區預測
    • 國家市場分析
  • 呼吸系統疾病
    • 市場規模和地區預測
    • 國家市場分析
  • 神經系統疾病
    • 市場規模和地區預測
    • 國家市場分析
  • 其他
    • 市場規模和地區預測
    • 國家市場分析

第7章按地區進行市場分析

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢和機遇
    • 國家市場分析
    • 市場規模和類型預測
    • 市場規模和相關組織的預測
    • 市場規模和按應用預測
  • 歐洲
    • 主要市場趨勢和機遇
    • 國家市場分析
    • 市場規模和類型預測
    • 市場規模和相關組織的預測
    • 市場規模和按應用預測
  • 亞太地區
    • 主要市場趨勢和機遇
    • 國家市場分析
    • 市場規模和類型預測
    • 市場規模和相關組織的預測
    • 市場規模和按應用預測
  • 中東
    • 主要市場趨勢和機遇
    • 國家市場分析
    • 市場規模和類型預測
    • 市場規模和相關組織的預測
    • 市場規模和按應用預測
  • 拉丁美洲和非洲
    • 主要市場趨勢和機遇
    • 國家市場分析
    • 市場規模和類型預測
    • 市場規模和相關組織的預測
    • 市場規模和按應用預測

第8章公司簡介

  • BOSTON SCIENTIFIC CORPORATION
  • DEXCOM, INC.
  • FITBIT, INC. (TWINE HEALTH, INC.)
  • KONINKLIJKE PHILIPS N.V. (PHILIPS)
  • LIVONGO HEALTH, INC.
  • MEDTRONIC PLC.
  • OMADA HEALTH, INC.
  • OMRON CORPORATION (OMRON HEALTHCARE, INC.)
  • SAMSUNG ELECTRONICS CO., LTD.
  • WELLDOC, INC.
目錄
Product Code: A00015

Title:
mHealth Market
by Type (mHealth Devices and mHealth Services), Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers, and Content Players), and Application (Cardiovascular Diseases, Diabetes, Respiratory diseases, Neurological Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The mHealth market accounted for $46,048 million in 2019, and is expected to reach $230,419 million by 2027, registering a CAGR of 22.3% from 2020 to 2027.

Electronic health (eHealth) is defined as collection and storage of patient data on a computer. Furthermore, Mobile health (mHealth) is a branch of eHealth, which involves the use of mobile devices such as mobile phones, tablets, wearable devices, personal digitals assistants (PDAs), and others to collect and store medical data. In addition, mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders. Some of the other services, offered by the use of mHealth include, prevention of diseases, diagnosis of diseases, and wellness & healthcare system strengthening solutions. In addition, some of the clinical fields that use mHealth devices and services include cardiovascular diseases, diabetes, respiratory, neurology, and others. Furthermore, some of the mHealth devices present in the market include blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, and others.

The major factors that contribute toward the growth of the mHealth market include rise in prevalence of lifestyle disorders. Furthermore, factors such as technological innovations, and favorable government initiatives also boost the growth of the mHealth market. In addition, integration of wireless technologies with portable healthcare devices is another major factor that fuels the growth of the market. Moreover, affordability of smartphones and rise in adoption of mHealth among medical professionals also boost the growth of the market.

However, weak reimbursement coverage associated with mHealth and lack of technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mHealth market.

The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is classified into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, rest of Middle East), and Latin America & Africa.

Major players operating in the market include Bayer Healthcare., Boston Scientific Corporation, Dexcom, Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Omron Corporation, Samsung Group, and Sanofi.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current global antihypertensive market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.

The market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative products facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Type

mHealth Devices

Blood Glucose Meters

BP Monitors

Pulse Oximetry

Neurological Monitors

Cardiac Monitors

Apnea & Sleep Monitors

Wearable Fitness Sensor Device & Heart Rate Meters

Others

mHealth Services

Prevention

Diagnostic Services

Monitoring Services

Treatment

Wellness & Healthcare System Strengthening Solutions

By Stakeholders

Mobile Operators

Device Vendors

Healthcare Providers

Application & Content Players

By Application

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Neurological Diseases

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Russia

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia-Pacific

Middle East

Saudi Arabia

Kuwait

UAE

Qatar

Bahrain

Oman

Rest of Middle East

Latin America

Latin America

Africa

List of key players profiled in the report

Bayer Healthcare

Boston Scientific Corporation

Dexcom, Inc.

Johnson & Johnson

Koninklijke Philips N.V.

Masimo Corporation

Medtronic plc

Omron Corporation

Samsung Group

Sanofi

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Allscripts Healthcare Solutions, Inc.

SoftServe, Inc.,

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
    • 1.2.1.List of key players profiled in the report
  • 1.3.Research methodology
    • 1.3.1.Primary research
    • 1.3.2.Secondary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Top player positioning
    • 3.2.1.Top investment pockets
  • 3.3.Key forces shaping mHealth industry/Market (mHealth devices)
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Rise in prevalence of lifestyle disorders across the globe
      • 3.4.1.2.Favorable governmental initiatives
      • 3.4.1.3.Affordability of smartphones
      • 3.4.1.4.Cost and convenience factors
    • 3.4.2.Restraint
      • 3.4.2.1.Concerns related to ensuring regulatory compliance
    • 3.4.3.Opportunities
      • 3.4.3.1.High growth potential in developing countries
    • 3.4.4.Impact Analyses

CHAPTER 4:MHEALTH MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.mHealth Devices
    • 4.2.1.Key market trends, growth factors and opportunities
    • 4.2.2.Market size and forecast, by type
      • 4.2.2.1.Blood Glucose Meter
      • 4.2.2.1.1.Market size and forecast
      • 4.2.2.2.BP Monitors
      • 4.2.2.2.1.Market size and forecast
      • 4.2.2.3.Pulse Oximetry
      • 4.2.2.3.1.Market size and forecast
      • 4.2.2.4.Neurological Monitors
      • 4.2.2.4.1.Market size and forecast
      • 4.2.2.5.Cardiac Monitors
      • 4.2.2.5.1.Market size and forecast
      • 4.2.2.6.Apnea & Sleep Monitors
      • 4.2.2.6.1.Market size and forecast
      • 4.2.2.7.Wearable Fitness Sensor Device & Heart Rate Meters
      • 4.2.2.7.1.Market size and forecast
      • 4.2.2.8.Others
      • 4.2.2.8.1.Market size and forecast
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.mHealth Services
    • 4.3.1.Key market trends, growth factors and opportunities
    • 4.3.2.Market size and forecast, by type
      • 4.3.2.1.Prevention Services
      • 4.3.2.1.1.Market size and forecast
      • 4.3.2.2.Diagnostic Services
      • 4.3.2.2.1.Market size and forecast
      • 4.3.2.3.Monitoring Services
      • 4.3.2.3.1.Market size and forecast
      • 4.3.2.4.Treatment Services
      • 4.3.2.4.1.Market size and forecast
      • 4.3.2.5.Wellness & Healthcare System Strengthening Solutions
      • 4.3.2.5.1.Market size and forecast
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country

CHAPTER 5:MHEALTH MARKET, BY STAKEHOLDERS

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Mobile operator
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis by country
  • 5.3.Device Vendors
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis by country
  • 5.4.Healthcare Providers
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis by country
  • 5.5.Application and Content Players
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis by country

CHAPTER 6:MHEALTH MARKET, BY APPLICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Cardiovascular Diseases
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis by country
  • 6.3.Diabetes
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis by country
  • 6.4.Respiratory Diseases
    • 6.4.1.Market size and forecast, by region
    • 6.4.2.Market analysis by country
  • 6.5.Neurology Diseases
    • 6.5.1.Market size and forecast, by region
    • 6.5.2.Market analysis by country
  • 6.6.Others
    • 6.6.1.Market size and forecast, by region
    • 6.6.2.Market analysis by country

CHAPTER 7:MHEALTH MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.Market analysis by country
      • 7.2.2.1.U.S.
      • 7.2.2.1.1.U.S. market size and forecast, by type
      • 7.2.2.1.1.1.U.S. mHealth devices market size and forecast, by type
      • 7.2.2.1.1.2.U.S. mHealth services market size and forecast, by type
      • 7.2.2.1.2.U.S. market size and forecast, by stakeholders
      • 7.2.2.1.3.U.S. market size and forecast, by application
      • 7.2.2.2.Canada
      • 7.2.2.2.1.Canada market size and forecast, by type
      • 7.2.2.2.1.1.Canada mHealth devices market size and forecast, by type
      • 7.2.2.2.1.2.Canada mHealth services market size and forecast, by type
      • 7.2.2.2.2.Canada market size and forecast, by stakeholders
      • 7.2.2.2.3.Canada market size and forecast, by application
      • 7.2.2.3.Mexico
      • 7.2.2.3.1.Mexico market size and forecast, by type
      • 7.2.2.3.1.1.Mexico mHealth devices market size and forecast, by type
      • 7.2.2.3.1.2.Mexico mHealth services market size and forecast, by type
      • 7.2.2.3.2.Mexico market size and forecast, by stakeholders
      • 7.2.2.3.3.Mexico market size and forecast, by application
    • 7.2.3.North America market size and forecast, by type
      • 7.2.3.1.North America mHealth devices market size and forecast, by type
      • 7.2.3.2.North America mHealth services market size and forecast, by type
    • 7.2.4.North America market size and forecast, by stakeholders
    • 7.2.5.North America market size and forecast, by application
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Market analysis by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany market size and forecast, by type
      • 7.3.2.1.1.1.Germany mHealth devices market size and forecast, by type
      • 7.3.2.1.1.2.Germany mHealth services market size and forecast, by type
      • 7.3.2.1.2.Germany market size and forecast, by stakeholders
      • 7.3.2.1.3.Germany market size and forecast, by application
      • 7.3.2.2.France
      • 7.3.2.2.1.France market size and forecast, by type
      • 7.3.2.2.1.1.France mHealth devices market size and forecast, by type
      • 7.3.2.2.1.2.France mHealth services market size and forecast, by type
      • 7.3.2.2.2.France market size and forecast, by stakeholders
      • 7.3.2.2.3.France market size and forecast, by application
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK market size and forecast, by type
      • 7.3.2.3.1.1.UK mHealth devices market size and forecast, by type
      • 7.3.2.3.1.2.UK mHealth services market size and forecast, by type
      • 7.3.2.3.2.UK market size and forecast, by stakeholders
      • 7.3.2.3.3.UK market size and forecast, by application
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy market size and forecast, by type
      • 7.3.2.4.1.1.Italy mHealth devices market size and forecast, by type
      • 7.3.2.4.1.2.Italy mHealth services market size and forecast, by type
      • 7.3.2.4.2.Italy market size and forecast, by stakeholders
      • 7.3.2.4.3.Italy market size and forecast, by application
      • 7.3.2.5.Russia
      • 7.3.2.5.1.Russia market size and forecast, by type
      • 7.3.2.5.1.1.Russia mHealth devices market size and forecast, by type
      • 7.3.2.5.1.2.Russia mHealth services market size and forecast, by type
      • 7.3.2.5.2.Russia market size and forecast, by stakeholders
      • 7.3.2.5.3.Russia market size and forecast, by application
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe market size and forecast, by type
      • 7.3.2.6.1.1.Rest of Europe mHealth devices market size and forecast, by type
      • 7.3.2.6.1.2.Rest of Europe mHealth services market size and forecast, by type
      • 7.3.2.6.2.Rest of Europe market size and forecast, by stakeholders
      • 7.3.2.6.3.Rest of Europe market size and forecast, by application
    • 7.3.3.Europe market size and forecast, by type
      • 7.3.3.1.Europe mHealth devices market size and forecast, by type
      • 7.3.3.2.Europe mHealth services market size and forecast, by type
    • 7.3.4.Europe market size and forecast, by stakeholders
    • 7.3.5.Europe market size and forecast, by application
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Market analysis by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan market size and forecast, by type
      • 7.4.2.1.1.1.Japan mHealth devices market size and forecast, by type
      • 7.4.2.1.1.2.Japan mHealth services market size and forecast, by type
      • 7.4.2.1.2.Japan market size and forecast, by stakeholders
      • 7.4.2.1.3.Japan market size and forecast, by application
      • 7.4.2.2.China
      • 7.4.2.2.1.China market size and forecast, by type
      • 7.4.2.2.1.1.China mHealth devices market size and forecast, by type
      • 7.4.2.2.1.2.China mHealth services market size and forecast, by type
      • 7.4.2.2.2.China market size and forecast, by stakeholders
      • 7.4.2.2.3.China market size and forecast, by application
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia market size and forecast, by type
      • 7.4.2.3.1.1.Australia mHealth devices market size and forecast, by type
      • 7.4.2.3.1.2.Australia mHealth services market size and forecast, by type
      • 7.4.2.3.2.Australia market size and forecast, by stakeholders
      • 7.4.2.3.3.Australia market size and forecast, by application
      • 7.4.2.4.India
      • 7.4.2.4.1.India market size and forecast, by type
      • 7.4.2.4.1.1.India mHealth devices market size and forecast, by type
      • 7.4.2.4.1.2.India mHealth services market size and forecast, by type
      • 7.4.2.4.2.India market size and forecast, by stakeholders
      • 7.4.2.4.3.India market size and forecast, by application
      • 7.4.2.5.Rest of Asia-Pacific
      • 7.4.2.5.1.Rest of Asia-Pacific market size and forecast, by type
      • 7.4.2.5.1.1.Rest of Asia-Pacific mHealth devices market size and forecast, by type
      • 7.4.2.5.1.2.Rest of Asia-Pacific mHealth services market size and forecast, by type
      • 7.4.2.5.2.Rest of Asia-Pacific market size and forecast, by stakeholders
      • 7.4.2.5.3.Rest of Asia-Pacific market size and forecast, by application
    • 7.4.3.Asia-Pacific market size and forecast, by type
      • 7.4.3.1.Asia-Pacific mHealth devices market size and forecast, by type
      • 7.4.3.2.Asia-Pacific mHealth services market size and forecast, by type
    • 7.4.4.Asia-Pacific market size and forecast, by stakeholders
    • 7.4.5.Asia-Pacific market size and forecast, by application
  • 7.5.Middle East
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.Market analysis by country
      • 7.5.2.1.Saudi Arabia
      • 7.5.2.1.1.Saudi Arabia market size and forecast, by type
      • 7.5.2.1.1.1.Saudi Arabia mHealth devices market size and forecast, by type
      • 7.5.2.1.1.2.Saudi Arabia mHealth services market size and forecast, by type
      • 7.5.2.1.2.Saudi Arabia market size and forecast, by stakeholders
      • 7.5.2.1.3.Saudi Arabia market size and forecast, by application
      • 7.5.2.2.Kuwait
      • 7.5.2.2.1.Kuwait market size and forecast, by type
      • 7.5.2.2.1.1.Kuwait mHealth devices market size and forecast, by type
      • 7.5.2.2.1.2.Kuwait mHealth services market size and forecast, by type
      • 7.5.2.2.2.Kuwait market size and forecast, by stakeholders
      • 7.5.2.2.3.Kuwait market size and forecast, by application
      • 7.5.2.3.UAE
      • 7.5.2.3.1.UAE market size and forecast, by type
      • 7.5.2.3.1.1.UAE mHealth devices market size and forecast, by type
      • 7.5.2.3.1.2.UAE mHealth services market size and forecast, by type
      • 7.5.2.3.2.UAE market size and forecast, by stakeholders
      • 7.5.2.3.3.UAE market size and forecast, by application
      • 7.5.2.4.Qatar
      • 7.5.2.4.1.Qatar market size and forecast, by type
      • 7.5.2.4.1.1.Qatar mHealth devices market size and forecast, by type
      • 7.5.2.4.1.2.Qatar mHealth services market size and forecast, by type
      • 7.5.2.4.2.Qatar market size and forecast, by stakeholders
      • 7.5.2.4.3.Qatar market size and forecast, by application
      • 7.5.2.5.Bahrain
      • 7.5.2.5.1.Bahrain market size and forecast, by type
      • 7.5.2.5.1.1.Bahrain mHealth devices market size and forecast, by type
      • 7.5.2.5.1.2.Bahrain mHealth services market size and forecast, by type
      • 7.5.2.5.2.Bahrain market size and forecast, by stakeholders
      • 7.5.2.5.3.Bahrain market size and forecast, by application
      • 7.5.2.6.Oman
      • 7.5.2.6.1.Oman market size and forecast, by type
      • 7.5.2.6.1.1.Oman mHealth devices market size and forecast, by type
      • 7.5.2.6.1.2.Oman mHealth services market size and forecast, by type
      • 7.5.2.6.2.Oman market size and forecast, by stakeholders
      • 7.5.2.6.3.Oman market size and forecast, by application
      • 7.5.2.7.Rest of Middle East
      • 7.5.2.7.1.Rest of Middle East market size and forecast, by type
      • 7.5.2.7.1.1.Rest of Middle East mHealth devices market size and forecast, by type
      • 7.5.2.7.1.2.Rest of Middle East mHealth services market size and forecast, by type
      • 7.5.2.7.2.Rest of Middle East market size and forecast, by stakeholders
      • 7.5.2.7.3.Rest of Middle East market size and forecast, by application
    • 7.5.3.Middle East market size and forecast, by type
      • 7.5.3.1.Middle East mHealth devices market size and forecast, by type
      • 7.5.3.2.Middle East mHealth services market size and forecast, by type
    • 7.5.4.Middle East market size and forecast, by stakeholders
    • 7.5.5.Middle East market size and forecast, by application
  • 7.6.Latin America & Africa
    • 7.6.1.Key market trends and opportunities
    • 7.6.2.Market analysis by country
      • 7.6.2.1.Latin America
      • 7.6.2.1.1.Latin America market size and forecast, by type
      • 7.6.2.1.1.1.Latin America mHealth devices market size and forecast, by type
      • 7.6.2.1.1.2.Latin America mHealth services market size and forecast, by type
      • 7.6.2.1.2.Latin America market size and forecast, by stakeholders
      • 7.6.2.1.3.Latin America market size and forecast, by application
      • 7.6.2.2.Africa
      • 7.6.2.2.1.Africa market size and forecast, by type
      • 7.6.2.2.1.1.Africa mHealth devices market size and forecast, by type
      • 7.6.2.2.1.2.Africa mHealth services market size and forecast, by type
      • 7.6.2.2.2.Africa market size and forecast, by stakeholders
      • 7.6.2.2.3.Africa market size and forecast, by application
    • 7.6.3.Latin America & Africa market size and forecast, by type
      • 7.6.3.1.Latin America & Africa mHealth devices market size and forecast, by type
      • 7.6.3.2.Latin America & Africa mHealth services market size and forecast, by type
    • 7.6.4.Latin America & Africa market size and forecast, by stakeholders
    • 7.6.5.Latin America & Africa market size and forecast, by application

CHAPTER 8:COMPANY PROFILES

  • 8.1.BOSTON SCIENTIFIC CORPORATION
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product Portfolio
    • 8.1.5.Business performance
  • 8.2.DEXCOM, INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product Portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.FITBIT, INC. (TWINE HEALTH, INC.)
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.KONINKLIJKE PHILIPS N.V. (PHILIPS)
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
    • 8.4.6.Key strategic moves and developments
  • 8.5.LIVONGO HEALTH, INC.
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Key strategic moves and developments
  • 8.6.MEDTRONIC PLC.
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.OMADA HEALTH, INC.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Key strategic moves and developments
  • 8.8.OMRON CORPORATION (OMRON HEALTHCARE, INC.)
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.SAMSUNG ELECTRONICS CO., LTD.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
  • 8.10.WELLDOC, INC.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.GLOBAL MHEALTH MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 02.MHEALTH DEVCIES MARKET, BY TYPE 2019-2027 ($MILLION)
  • TABLE 03.BLOOD GLUCOSE METER MARKET, 2019-2027 ($MILLION)
  • TABLE 04.BP MONITORS MARKET, 2019-2027 ($MILLION)
  • TABLE 05.PULSE OXIMETRY MARKET, 2019-2027 ($MILLION)
  • TABLE 06.NEUROLOGICAL MONITORS MARKET, 2019-2027 ($MILLION)
  • TABLE 07.CARDIAC MONITORS MARKET, 2019-2027 ($MILLION)
  • TABLE 08.APNEA & SLEEP MONITORS MARKET, 2019-2027 ($MILLION)
  • TABLE 09.WEARABLE FITNESS SENSOR DEVICE & HEART RATE METERS MARKET, 2019-2027 ($MILLION)
  • TABLE 10.OTHERS MARKET, 2019-2027 ($MILLION)
  • TABLE 11.MHEALTH DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.MHEALTH SERVICES MARKET, BY TYPE 2019-2027 ($MILLION)
  • TABLE 13.PREVENTION SERVICES MARKET, 2019-2027 ($MILLION)
  • TABLE 14.DIAGNOSTIC SERVIES MARKET, 2019-2027 ($MILLION)
  • TABLE 15.MONITORING SERVIES MARKET, 2019-2027 ($MILLION)
  • TABLE 16.TREATMENT SERVICES MARKET, 2019-2027 ($MILLION)
  • TABLE 17.WELLNESS & HEALTHCARE SYSTEM STRENGTHENING SOLUTIONS MARKET, 2019-2027 ($MILLION)
  • TABLE 18.MHEALTH SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2019-2027 ($MILLION)
  • TABLE 20.MHEALTH MARKET FOR MOBILE OPERATOR, BY REGION 2019-2027($MILLION)
  • TABLE 21.MHEALTH MARKET FOR DEVCIE VENDORS, BY REGION 2019-2027 ($MILLION)
  • TABLE 22.MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY REGION 2019-2027 ($MILLION)
  • TABLE 23.MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY REGION 2019-2027 ($MILLION)
  • TABLE 24.GLOBAL MHEALTH MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 25.MHEALTH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION 2019-2027($MILLION)
  • TABLE 26.MHEALTH MARKET FOR DEVCIE VENDORS, BY REGION 2019-2027 ($MILLION)
  • TABLE 27.MHEALTH MARKET FOR RESPIRATORY DISEASES, BY REGION 2019-2027 ($MILLION)
  • TABLE 28.MHEALTH MARKET FOR NEUROLOGICAL DISEASES, BY REGION 2019-2027 ($MILLION)
  • TABLE 29.MHEALTH MARKET FOR OTHERS, BY REGION 2019-2027 ($MILLION)
  • TABLE 30.MHEALTH MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 31.NORTH AMERICA MHEALTH MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 32.U.S. MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 33.U.S. MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 34.U.S. MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 35.U.S. MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 36.U.S. MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 37.CANADA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 38.CANADA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 39.CANADA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 40.CANADA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 41.CANADA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 42.MEXICO MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 43.MEXICO MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 44.MEXICO MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 45.MEXICO MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 46.MEXICO MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 47.NORTH AMERICA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 48.NORTH AMERICA MHEALTH DEVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 49.NORTH AMERICA MHEALTH SERVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 50.NORTH AMERICA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027($MILLION)
  • TABLE 51.NORTH AMERICA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027($MILLION)
  • TABLE 52.EUROPE MHEALTH MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 53.GERMANY MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 54.GERMANY MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 55.GERMANY MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 56.GERMANY MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 57.GERMANY MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 58.FRANCE MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 59.FRANCE MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 60.FRANCE MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 61.FRANCE MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 62.FRANCE MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 63.UK MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 64.UK MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 65.UK MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 66.UK MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 67.UK MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 68.ITALY MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 69.ITALY MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 70.ITALY MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 71.ITALY MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 72.ITALY MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 73.RUSSIA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 74.RUSSIA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 75.RUSSIA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 76.RUSSIA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 77.RUSSIA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 78.REST OF EUROPE MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 79.REST OF EUROPE MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 80.REST OF EUROPE MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 81.REST OF EUROPE MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 82.REST OF EUROPE MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 83.EUROPE MHEALTH MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 84.EUROPE MHEALTH DEVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 85.EUROPE MHEALTH SERVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 86.EUROPE MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027($MILLION)
  • TABLE 87.EUROPE MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027($MILLION)
  • TABLE 88.ASIA-PACIFIC MHEALTH MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 89.JAPAN MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 90.JAPAN MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 91.JAPAN MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 92.JAPAN MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 93.JAPAN MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 94.CHINA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 95.CHINA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 96.CHINA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 97.CHINA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 98.CHINA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 99.AUSTRALIA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 100.AUSTRALIA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 101.AUSTRALIA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 102.AUSTRALIA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 103.AUSTRALIA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 104.INDIA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 105.INDIA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 106.INDIA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 107.INDIA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 108.INDIA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 109.REST OF ASIA-PACIFIC MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 110.REST OF ASIA-PACIFIC MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 111.REST OF ASIA-PACIFIC MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 112.REST OF ASIA-PACIFIC MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 113.REST OF ASIA-PACIFIC MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 114.ASIA-PACIFIC MHEALTH MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 115.ASIA-PACIFIC MHEALTH DEVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 116.ASIA-PACIFIC MHEALTH SERVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 117.ASIA-PACIFIC MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027($MILLION)
  • TABLE 118.ASIA-PACIFIC MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027($MILLION)
  • TABLE 119.MIDDLE EAST MHEALTH MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 120.SAUDI ARABIA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 121.SAUDI ARABIA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 122.SAUDI ARABIA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 123.SAUDI ARABIA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 124.SAUDI ARABIA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 125.KUWAIT MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 126.KUWAIT MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 127.KUWAIT MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 128.KUWAIT MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 129.KUWAIT MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 130.UAE MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 131.UAE MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 132.UAE MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 133.UAE MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 134.UAE MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 135.QATAR MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 136.QATAR MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 137.QATAR MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 138.QATAR MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 139.QATAR MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 140.BAHRAIN MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 141.BAHRAIN MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 142.BAHRAIN MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 143.BAHRAIN MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 144.BAHRAIN MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 145.OMAN MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 146.OMAN MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 147.OMAN MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 148.OMAN MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 149.OMAN MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 150.REST OF MIDDLE EAST MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 151.REST OF MIDDLE EAST MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 152.REST OF MIDDLE EAST MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 153.REST OF MIDDLE EAST MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 154.REST OF MIDDLE EAST MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 155.MIDDLE EAST MHEALTH MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 156.MIDDLE EAST MHEALTH DEVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 157.MIDDLE EAST MHEALTH SERVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 158.MIDDLE EAST MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027($MILLION)
  • TABLE 159.MIDDLE EAST MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027($MILLION)
  • TABLE 160.LATIN AMERICA & AFRICA MHEALTH MARKET REVENUE, BY COUNTRY, 2020-2027 ($MILLION)
  • TABLE 161.LATIN AMERICA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 162.LATIN AMERICA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 163.LATIN AMERICA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 164.LATIN AMERICA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 165.LATIN AMERICA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 166.AFRICA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027 ($MILLION)
  • TABLE 167.AFRICA MHEALTH DEVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 168.AFRICA MHEALTH SERVICES MARKET, 2020-2027 ($MILLION)
  • TABLE 169.AFRICA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027 ($MILLION)
  • TABLE 170.AFRICA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027 ($MILLION)
  • TABLE 171.LATIN AMERICA & AFRICA MHEALTH MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 172.LATIN AMERICA & AFRICA MHEALTH DEVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 173.LATIN AMERICA & AFRICA MHEALTH SERVICES MARKET REVENUE, BY TYPE, 2020-2027($MILLION)
  • TABLE 174.LATIN AMERICA & AFRICA MHEALTH MARKET REVENUE, BY STAKEHOLDERS, 2020-2027($MILLION)
  • TABLE 175.LATIN AMERICA & AFRICA MHEALTH MARKET REVENUE, BY APPLICATION, 2020-2027($MILLION)
  • TABLE 176.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 177.BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 178.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 179.DEXCOM: COMPANY SNAPSHOT
  • TABLE 180.DEXCOM: PRODUCT PORTFOLIO
  • TABLE 181.FITBIT: COMPANY SNAPSHOT
  • TABLE 182.FITBIT: PRODUCT PORTFOLIO
  • TABLE 183.PHILIPS: COMPANY SNAPSHOT
  • TABLE 184.PHILIPS: OPERATING SEGMENTS
  • TABLE 185.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 186.LIVONGO: COMPANY SNAPSHOT
  • TABLE 187.LIVONGO: PRODUCT PORTFOLIO
  • TABLE 188.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 189.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 190.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 191.OMADA: COMPANY SNAPSHOT
  • TABLE 192.OMADA: PRODUCT PORTFOLIO
  • TABLE 193.OMRON: COMPANY SNAPSHOT
  • TABLE 194.OMRON: OPERATING SEGMENTS
  • TABLE 195.OMRON: PRODUCT PORTFOLIO
  • TABLE 196.SAMSUNG: COMPANY SNAPSHOT
  • TABLE 197.SAMSUNG: OPERATING SEGMENTS
  • TABLE 198.SAMSUNG PRODUCT PORTFOLIO
  • TABLE 199.WELLDOC: COMPANY SNAPSHOT
  • TABLE 200.WELLDOC: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL MHEALTH MARKET SEGMENTATION
  • FIGURE 02.TOP PLAYER POSITIONING, 2018
  • FIGURE 03.TOP INVESTMENT POCKETS
  • FIGURE 04.HIGH BARGAINING POWER OF SUPPLIER
  • FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06.HIGH THREAT OF SUBSTITUTES
  • FIGURE 07.MODERATE INTENSITY OF RIVALRY
  • FIGURE 08.LOW THREAT OF NEW ENTRANT
  • FIGURE 09.OWNERSHIP OF SMARTPHONES IN PEOPLE AGED 18 TO 34 YEARS IN DEVELOPING COUNTRIES, 2015-2018 (%)
  • FIGURE 10.OWNERSHIP OF SMARTPHONES IN PEOPLE AGED 18 TO 34 YEARS IN DEVELOPEDCOUNTRIES, 2015-2018 (%)
  • FIGURE 11.IMPACT ANALYSES, MHEALTH MARKET
  • FIGURE 12.COMPARATIVE ANALYSIS OF MHEALTH DEVCIES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 13.COMPARATIVE ANALYSIS OF MHEALTH SERVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR MOBILE OPERATORS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DEVICE VENDORS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR APPLICATION AND CONTENT PLAYERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR CARDIOVASCULAR DISEASESS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR DIABETES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MHEALTH MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 23.U.S. MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 24.CANADA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 25.MEXICO MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 26.OWNERSHIP OF SMARTPHONES IN PEOPLE AGED ABOVE 50 YEARS IN EUROPEAN COUNTRIES, 2015-2018 (%)
  • FIGURE 27.GERMANY MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 28.FRANCE MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 29.UK MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 30.ITALY MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 31.RUSSIA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 32.REST OF EUROPE MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 33.JAPAN MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 34.CHINA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 35.AUSTRALIA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 36.INDIA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 37.REST OF ASIA-PACIFIC MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 38.SAUDI ARABIA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 39.KUWAIT MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 40.UAE MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 41.QATAR MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 42.BAHRAIN MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 43.OMAN MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 44.REST OF MIDDLE EAST MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 45.LATIN AMERICA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 46.AFRICA MHEALTH MARKET, 2020-2027 ($MILLION)
  • FIGURE 47.BOSTON SCIENTIFIC: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 48.BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2018 (%)
  • FIGURE 49.BOSTON SCIENTIFIC: NET SALES, BY REGION, 2018 (%)
  • FIGURE 50.DEXCOM: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 51.DEXCOM: NET SALES BY REGION, 2018 (%)
  • FIGURE 52.FITBIT: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 53.FITBIT: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 54.PHILIPS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 55.PHILIPS: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 56.PHILIPS: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 57.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 58.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 59.MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 60.OMRON: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 61.OMRON: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 62.OMRON: REVENUE SHARE BY REGION, 2018 (%)
  • FIGURE 63.SAMSUNG: REVENUE, 2016-2018 ($MILLION)
  • FIGURE 64.SAMSUNG: REVENUE SHARE BY SEGMENT, 2018 (%)
  • FIGURE 65.SAMSUNG: REVENUE SHARE BY REGION, 2018 (%)